project id: TCGA-CESC; case submitter id: TCGA-EK-A2R7; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.88; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.3; rna integrity number: 8.2; age at index: 45; days to birth: -16487; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1965; age at diagnosis: 16487; ajcc pathologic m: M0; ajcc pathologic n: N1; ajcc pathologic t: T1b1; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 27.0; figo stage: Stage IB; icd 10 code: C53.9; last known disease status: not reported; morphology: 8072/3; primary diagnosis: Squamous cell carcinoma, large cell, nonkeratinizing, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cervix uteri; synchronous malignancy: No; tissue or organ of origin: Cervix uteri; tumor grade: Not Reported; year of diagnosis: 2010; treatment or therapy: not reported; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 546; initial weight: 100.0; oct embedded: false; preservation method: Unknown; sample id: ee9a22df-8612-4b71-af3a-6b16c73197ea; sample submitter id: TCGA-EK-A2R7-01A; portion id: 9ff04aac-76ba-4510-a094-543963dba685; portion submitter id: TCGA-EK-A2R7-01A-11; slide id: 5c28740a-66c5-4a8a-b0c3-813b0aafd2ec; slide submitter id: TCGA-EK-A2R7-01A-01-TS1; percent lymphocyte infiltration: 6.0; percent monocyte infiltration: 0.0; percent necrosis: 1.0; percent neutrophil infiltration: 0.0; percent normal cells: 19.0; percent stromal cells: 5.0; percent tumor cells: 75.0; percent tumor nuclei: 88.0; section location: TOP;